Chemoinformaics analysis of alpha-Liriodenolide
| Molecular Weight | 306.358 | nRot | 1 |
| Heavy Atom Molecular Weight | 284.182 | nRig | 18 |
| Exact Molecular Weight | 306.147 | nRing | 3 |
| Solubility: LogS | -2.676 | nHRing | 1 |
| Solubility: LogP | 1.396 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 47.0694 |
| nHD | 1 | BPOL | 27.2786 |
| QED | 0.454 |
| Synth | 4.621 |
| Natural Product Likeliness | 3.712 |
| NR-PPAR-gamma | 0.028 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.005 |
| HIA | 0.077 |
| CACO-2 | -4.816 |
| MDCK | 0.0000716 |
| BBB | 0.559 |
| PPB | 0.650115 |
| VDSS | 1.215 |
| FU | 0.336712 |
| CYP1A2-inh | 0.123 |
| CYP1A2-sub | 0.064 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.299 |
| CYP2c9-inh | 0.055 |
| CYP2c9-sub | 0.083 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.093 |
| CYP3a4-inh | 0.188 |
| CYP3a4-sub | 0.203 |
| CL | 5.405 |
| T12 | 0.787 |
| hERG | 0.078 |
| Ames | 0.162 |
| ROA | 0.943 |
| SkinSen | 0.535 |
| Carcinogencity | 0.074 |
| EI | 0.308 |
| Respiratory | 0.953 |
| NR-Aromatase | 0.82 |
| Antiviral | Yes |
| Prediction | 0.811124 |